Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Respiratory microbiology of patients with cystic fibrosis in the United States, 1995 to 2005.

Razvi S, Quittell L, Sewall A, Quinton H, Marshall B, Saiman L.

Chest. 2009 Dec;136(6):1554-1560. doi: 10.1378/chest.09-0132. Epub 2009 Jun 8.

PMID:
19505987
2.

Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.

Psoter KJ, De Roos AJ, Wakefield J, Mayer JD, Rosenfeld M.

BMC Infect Dis. 2017 Jun 9;17(1):411. doi: 10.1186/s12879-017-2511-9.

3.

Changing Epidemiology of the Respiratory Bacteriology of Patients With Cystic Fibrosis.

Salsgiver EL, Fink AK, Knapp EA, LiPuma JJ, Olivier KN, Marshall BC, Saiman L.

Chest. 2016 Feb;149(2):390-400. doi: 10.1378/chest.15-0676. Epub 2016 Jan 12.

PMID:
26203598
4.

Unusual respiratory bacterial flora in cystic fibrosis: microbiologic and clinical features.

Beringer PM, Appleman MD.

Curr Opin Pulm Med. 2000 Nov;6(6):545-50. Review.

PMID:
11100967
5.

Molecular epidemiology of Pseudomonas aeruginosa, Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus in a cystic fibrosis center.

Campana S, Taccetti G, Ravenni N, Masi I, Audino S, Sisi B, Repetto T, Döring G, de Martino M.

J Cyst Fibros. 2004 Aug;3(3):159-63.

6.

Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center.

Vu-Thien H, Moissenet D, Valcin M, Dulot C, Tournier G, Garbarg-Chenon A.

Eur J Clin Microbiol Infect Dis. 1996 Nov;15(11):876-9.

PMID:
8997562
7.

Pathogenicity of microbes associated with cystic fibrosis.

Hutchison ML, Govan JR.

Microbes Infect. 1999 Oct;1(12):1005-14. Review.

PMID:
10617932
8.

Pathophysiology and management of pulmonary infections in cystic fibrosis.

Gibson RL, Burns JL, Ramsey BW.

Am J Respir Crit Care Med. 2003 Oct 15;168(8):918-51. Review.

PMID:
14555458
9.

[Bacterial isolates from respiratory samples of pediatric patients with cystic fibrosis and their distribution by ages].

Busquets NP, Baroni MR, Ochoteco MC, Zurbriggen ML, Virgolini S, Meneghetti FG.

Rev Argent Microbiol. 2013 Jan-Mar;45(1):44-9. Spanish.

11.

Increasing Incidence of Multidrug Resistance Among Cystic Fibrosis Respiratory Bacterial Isolates.

Rutter WC, Burgess DR, Burgess DS.

Microb Drug Resist. 2017 Jan;23(1):51-55. doi: 10.1089/mdr.2016.0048. Epub 2016 Jun 21.

PMID:
27326758
12.

Antibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infections.

Chmiel JF, Aksamit TR, Chotirmall SH, Dasenbrook EC, Elborn JS, LiPuma JJ, Ranganathan SC, Waters VJ, Ratjen FA.

Ann Am Thorac Soc. 2014 Sep;11(7):1120-9. doi: 10.1513/AnnalsATS.201402-050AS. Review.

13.

Microbiology of airway disease in a cohort of patients with cystic fibrosis.

Lambiase A, Raia V, Del Pezzo M, Sepe A, Carnovale V, Rossano F.

BMC Infect Dis. 2006 Jan 11;6:4.

14.

Changes in cystic fibrosis sputum microbiology in the United States between 1995 and 2008.

Emerson J, McNamara S, Buccat AM, Worrell K, Burns JL.

Pediatr Pulmonol. 2010 Apr;45(4):363-70. doi: 10.1002/ppul.21198.

PMID:
20232473
15.

Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Shreve MR, Butler S, Kaplowitz HJ, Rabin HR, Stokes D, Light M, Regelmann WE.

J Clin Microbiol. 1999 Mar;37(3):753-7.

17.

Association between Staphylococcus aureus alone or combined with Pseudomonas aeruginosa and the clinical condition of patients with cystic fibrosis.

Hubert D, Réglier-Poupet H, Sermet-Gaudelus I, Ferroni A, Le Bourgeois M, Burgel PR, Serreau R, Dusser D, Poyart C, Coste J.

J Cyst Fibros. 2013 Sep;12(5):497-503. doi: 10.1016/j.jcf.2012.12.003. Epub 2013 Jan 3.

18.

[Microbiological diagnosis of bronchopulmonary colonization-infection in cystic fibrosis].

Oliver A, Alarcón T, Caballero E, Cantón R.

Enferm Infecc Microbiol Clin. 2009 Feb;27(2):89-104. doi: 10.1016/j.eimc.2008.05.004. Epub 2009 Feb 20. Review. Spanish.

PMID:
19232782
19.

Clinical characteristics and epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in children with cystic fibrosis from a center with a high MRSA prevalence.

Harik NS, Com G, Tang X, Melguizo Castro M, Stemper ME, Carroll JL.

Am J Infect Control. 2016 Apr 1;44(4):409-15. doi: 10.1016/j.ajic.2015.10.015. Epub 2015 Dec 9.

PMID:
26684366
20.

Denitrification by cystic fibrosis pathogens - Stenotrophomonas maltophilia is dormant in sputum.

Kolpen M, Kragh KN, Bjarnsholt T, Line L, Hansen CR, Dalbøge CS, Hansen N, Kühl M, Høiby N, Jensen PØ.

Int J Med Microbiol. 2015 Jan;305(1):1-10. doi: 10.1016/j.ijmm.2014.07.002. Epub 2014 Aug 10.

PMID:
25441256

Supplemental Content

Support Center